AMILI is the #1 precision gut microbiome company in Southeast Asia, based in Singapore. AMILI hosts Southeast Asia’s first and only gut microbiome transplant bank and the world’s largest multi-ethnic Asian gut microbiome database. Our precision-driven, end-to-end platform captures unparalleled insights into gut microbiome abundance, functionality, and its impact on health.
For more information, visit www.amili.asia.
Company Details
- Employees
- 57
- Founded
- 2019
- Address
- 89 Science Park Drive, The Rutherford Science Park 1, 03-09,singapore
- Phone
- +65 6977 7199
- he****@****li.asia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- amili.asia
- Keywords
- Gut Microbiome, Gut Health, Stool Bank, Faecal Microbiota Transplants, Research and Development, Innovation, Data, Gut Microbiome Testing, Personalised Probiotics.
- HQ
- Singapore, Central Singapore
Amili Questions
Amili's helpline number is +65 6977 7199
Amili's website is amili.asia
Amili's LinkedIn profile is https://sg.linkedin.com/company/amili-pte-ltd
Amili has
57 employees.
View email and phone details for 57
employees at Amili.
Amili's industry is
Biotechnology Research
Amili's top competitors are
Aevice Health,
Blueshirt Philippines,
Mental Health Action Trust (Mhat),
Nalagenetics,
Mito Health,
Seeds,
Omegaquant Analytics,
Lucence,
Allozymes,
Mesh Bio.
Amili's support email address is hello@amili.asia
Amili's categories are Biotechnology Research
Amili's founding year is 2019
